About Western Blotting
Western blotting also known as protein immunoblotting is a widely accepted analytical technique used to detect specific proteins in the given sample. Western blotting uses SDS-polyacrylamide gel electrophoresis (SDS-PAGE) to separate various proteins contained in the given sample. The separated proteins are then transferred or blotted onto a matrix, where they are stained with antibodies specific to the target protein. By analyzing the location and intensity of the specific reaction, expression details of the target proteins in the given cells or tissue homogenate could be obtained. It widely used in molecular biology, immunogenetics and other molecular biology disciplines.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Western Blotting market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific (United States), Cell Signaling Technology, Inc. (United States), Bio-Rad Laboratories, Inc. (United States), GE Healthcare (United States), Advansta, Inc. (United States), Bio-Techne Corporation (United States), PerkinElmer, Inc. (United States), Merck KGaA (Germany), Roche Holding AG (Switzerland) and LI-COR Biosciences (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sigma-Aldrich (United States) and EMD Millipore (United States).
Segmentation Overview
AMA Research has segmented the market of Global Western Blotting market by Type (Consumables {Reagents, Kits and Other} and Instruments {Blotting Systems (Wet and Semi-Dry) and Imagers (Chemiluminescent, Fluorescent and Other)}), Application (Biochemical and Biomedical Research, Disease Diagnostics, Agriculture and Other) and Region.
On the basis of geography, the market of Western Blotting has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User, the sub-segment i.e. Academic & Research Institutes will boost the Western Blotting market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Automation of Western Blotting Instruments
Market Growth Drivers:
Introduction of Advanced Diagnostic Technologies, Growing Incidence of HIV/AIDS and Investments in R&D by Different Pharmaceutical Companies
Challenges:
Requirement for High Procedural Efficiency and Stringent Regulations
Restraints:
Emergence of Alternative Technologies
Opportunities:
Rising Need for Personalized Medicine and Demand from Developing Countries
Market Leaders and their expansionary development strategies
In January 2021, Bio-Rad Laboratories, Inc. a global leader in life science research and clinical diagnostic products, has launched of the Bio-Rad Western Blotting Learning Center, an online library that provides comprehensive resources, information, and guidance to help researchers improve their experimental western blotting (or immunoblotting) approaches to obtain high-quality data.
In April 2022 , Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, has launched of its AvivaBlot™ product line of ECL reagents for western blot application. This new portfolio supports picogram to low femtogram detection of proteins via enhanced and stabilized chemiluminescent detection.
Key Target Audience
Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and End-user
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.